Does Rallies track congressional trades in SOLV?

Yes. Rallies tracks politician and congressional stock disclosures for SOLV, including reported purchases, sales, dates, owners, and trade amounts when available.

Is SOLV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SOLV. It does not provide personalized investment advice.

SOLV (Solventum Corporation) Stock Analysis - Politician Trades

Solventum Corporation (SOLV) is a publicly traded Healthcare sector company. As of May 21, 2026, SOLV trades at $76.13 with a market cap of $13.18B and a P/E ratio of 9.25. SOLV moved +1.79% today. Year to date, SOLV is -5.78%; over the trailing twelve months it is +1.91%. Its 52-week range spans $60.70 to $88.20. Analyst consensus is buy with an average price target of $82.70. Rallies surfaces SOLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded SOLV stock?

Recent politician trading activity in SOLV includes disclosures from James French Hill, Ron Wyden, Julie Johnson, Gary Peters, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

SOLV Key Metrics

Key financial metrics for SOLV
Metric	Value
Price	$76.13
Market Cap	$13.18B
P/E Ratio	9.25
EPS	$8.21
Dividend Yield	0.00%
52-Week High	$88.20
52-Week Low	$60.70
Volume	992.44K
Avg Volume	0
Revenue (TTM)	$8.26B
Net Income	$1.43B
Gross Margin	53.67%

Congressional Trades in SOLV

James French Hill sale SOLV on Dec 31, 2025 (amount: $50.00K).
Ron Wyden sale (full) SOLV on Feb 6, 2025 (amount: $15.00K) for Spouse.
Julie Johnson sale SOLV on Jan 15, 2025 (amount: $15.00K) for Joint.
Gary Peters sale (full) SOLV on May 14, 2024 (amount: $15.00K) for Self.
Tommy Tuberville purchase SOLV on May 3, 2024 (amount: $15.00K) for Joint.

Latest SOLV News

Solventum jumps after Q1 beat, nudges 2026 adjusted EPS toward high end — May 6, 2026
Solventum jumps after Q1 EPS beat, reaffirms 2026 outlook and flags high-end EPS — May 5, 2026
Solventum slides 3% as KeyBanc trims price target ahead of May 5 earnings — Apr 28, 2026
Solventum Q1 Report Set for May 5; Analysts Flag 58% EPS Overstatement — Apr 14, 2026
Solventum jumps as KeyBanc upgrade spotlights discounted medtech valuation — Apr 8, 2026

Recent SOLV Insider Trades

Wendell Amy McBride bought 1.48K (~$100.34K) on Mar 10, 2026.
3M CO sold 8.80M (~$646.36M) on Aug 15, 2025.

SOLV Analyst Consensus

12 analysts cover SOLV: 0 strong buy, 7 buy, 3 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $82.70.

Common questions about SOLV

Which politicians traded SOLV stock?: Recent politician trading activity in SOLV includes disclosures from James French Hill, Ron Wyden, Julie Johnson, Gary Peters, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in SOLV?: Yes. Rallies tracks politician and congressional stock disclosures for SOLV, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SOLV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SOLV. It does not provide personalized investment advice.